Sensorium Therapeutics

Sensorium Therapeutics is a biotechnology company that leverages medicinal chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive drugs for mental health. Founded by world-class researchers, clinicians, and drug developers from Massachusetts General Hospital and Harvard Medical School, Sensorium utilizes cutting-edge chemistry, neuroscience, and machine learning technologies to create plant- and fungi-based psychoactive drugs for mental health applications. Drawing on extensive historical evidence of safety and efficacy from the long-term human use of plants and fungi, Sensorium’s pioneering Biodynamics Discovery Platform™ rapidly identifies, replicates, adapts, and enhances targeted molecules, improving their utility as modern medicines to deliver transformative benefits to patients worldwide.